Violations of proportional hazard assumption in Cox regression model of transcriptomic data in TCGA pan-cancer cohorts

Visualizing and interpreting cancer genomics data via the Xena platform

(2020) Mary J. Goldman et al.   NATURE BIOTECHNOLOGY

Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma

(2020) Wenbiao Chen et al.   Journal of Immunology Research

RNA sequencing: the teenage years

(2019) Rory Stark et al.   NATURE REVIEWS GENETICS

Identification of a RNA-seq-based signature to improve prognostics for uterine sarcoma

(2019) Jian-Guo Zhou et al.   GYNECOLOGIC ONCOLOGY

Transcriptomic signature associated with carcinogenesis and aggressiveness of papillary thyroid carcinoma

(2018) Huajing Teng et al.   Theranostics

Prognostic Influence of BCL2 on Molecular Subtypes of Breast Cancer

(2017) Ki-Tae Hwang et al.   Journal of Breast Cancer

Germline INDELs and CNVs in a cohort of colorectal cancer patients: their characteristics, associations with relapse-free survival time, and potential time-varying effects on the risk of relapse

(2017) Salem Werdyani et al.   Cancer Medicine

Power and sample size calculation for the additive hazard model

(2016) Pei-Fang Su   Journal of Biopharmaceutical Statistics

The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible

(2016) Damian Szklarczyk et al.   NUCLEIC ACIDS RESEARCH

limma powers differential expression analyses for RNA-sequencing and microarray studies

(2015) Matthew E. Ritchie et al.   NUCLEIC ACIDS RESEARCH

Germline Mutation in BRCA1 or BRCA2 and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer

(2014) Francisco J. Candido-dos-Reis et al.   CLINICAL CANCER RESEARCH

Ward’s Hierarchical Agglomerative Clustering Method: Which Algorithms Implement Ward’s Criterion?

(2014) Fionn Murtagh et al.   JOURNAL OF CLASSIFICATION

Testing the proportional hazards assumption in case-cohort analysis

(2013) Xiaonan Xue et al.   BMC Medical Research Methodology

Validation of a Histology-Independent Prognostic Gene Signature for Early-Stage, Non–Small-Cell Lung Cancer Including Stage IA Patients

(2013) Sandy D. Der et al.   Journal of Thoracic Oncology

The Cancer Genome Atlas Pan-Cancer analysis project

(2013) John N Weinstein et al.   NATURE GENETICS

Biomarker Discovery in Non-Small Cell Lung Cancer: Integrating Gene Expression Profiling, Meta-analysis, and Tissue Microarray Validation

(2012) J. Botling et al.   CLINICAL CANCER RESEARCH

Gene selection in microarray survival studies under possibly non-proportional hazards

(2010) Daniela Dunkler et al.   BIOINFORMATICS

Variables with time-varying effects and the Cox model: Some statistical concepts illustrated with a prognostic factor study in breast cancer

(2010) Carine A Bellera et al.   BMC Medical Research Methodology

Immortal time bias in critical care research: Application of time-varying Cox regression for observational cohort studies*

(2009) Ayumi K. Shintani et al.   CRITICAL CARE MEDICINE

Survival End Point Reporting in Randomized Cancer Clinical Trials: A Review of Major Journals

(2008) Simone Mathoulin-Pelissier et al.   JOURNAL OF CLINICAL ONCOLOGY

Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

(2008) Kerby Shedden et al.   NATURE MEDICINE